S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$51.81
+0.3%
$53.32
$43.38
$62.88
$7.01B1.081.14 million shs757,042 shs
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$32.06
-2.3%
$37.69
$31.93
$59.30
$2.52B1.12646,867 shs625,348 shs
NuVasive, Inc. stock logo
NUVA
NuVasive
$39.75
$39.64
$35.17
$49.53
$2.08B1.071.16 million shsN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$210.66
-1.8%
$228.97
$177.63
$276.43
$9.92B1.11260,367 shs275,393 shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
+0.27%-2.58%+0.80%-6.36%-9.96%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
-2.26%-6.91%-7.61%-23.67%-45.64%
NuVasive, Inc. stock logo
NUVA
NuVasive
0.00%0.00%0.00%0.00%-6.47%
Teleflex Incorporated stock logo
TFX
Teleflex
-1.76%-2.88%-2.20%-14.33%-20.15%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.7059 of 5 stars
3.31.00.04.12.04.23.1
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
4.7806 of 5 stars
3.15.00.04.02.11.73.1
NuVasive, Inc. stock logo
NUVA
NuVasive
1.8896 of 5 stars
3.30.00.00.00.00.03.1
Teleflex Incorporated stock logo
TFX
Teleflex
4.7773 of 5 stars
3.33.01.73.92.32.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.67
Moderate Buy$66.3328.03% Upside
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
2.22
Hold$44.8940.02% Upside
NuVasive, Inc. stock logo
NUVA
NuVasive
2.50
Moderate Buy$51.3329.14% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.60
Moderate Buy$265.5626.06% Upside

Current Analyst Ratings

Latest GMED, IART, NUVA, and TFX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/3/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$38.00
3/18/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00
3/1/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$46.00 ➝ $41.00
2/29/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$55.00 ➝ $49.00
2/23/2024
Teleflex Incorporated stock logo
TFX
Teleflex
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$285.00
2/23/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$272.00 ➝ $265.00
2/23/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$270.00 ➝ $265.00
2/21/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$58.00 ➝ $60.00
2/21/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$61.00 ➝ $64.00
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.02B6.87$3.62 per share14.32$29.32 per share1.77
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$1.54B1.63$4.72 per share6.79$20.31 per share1.58
NuVasive, Inc. stock logo
NUVA
NuVasive
$1.23B1.70$4.96 per share8.01$17.02 per share2.34
Teleflex Incorporated stock logo
TFX
Teleflex
$2.97B3.34$18.50 per share11.39$94.49 per share2.23

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$122.87M$1.1744.2815.801.527.83%8.82%7.20%5/2/2024 (Estimated)
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$67.74M$0.8338.638.880.994.39%15.19%6.59%4/24/2024 (Estimated)
NuVasive, Inc. stock logo
NUVA
NuVasive
$40.41M$0.5079.5015.35N/A2.32%12.17%4.88%N/A
Teleflex Incorporated stock logo
TFX
Teleflex
$356.33M$7.5327.9813.862.0511.98%14.98%8.87%5/2/2024 (Estimated)

Latest GMED, IART, NUVA, and TFX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/28/202412/31/2023
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.90$0.89-$0.01$1.53$399.30 million$397.00 million    
2/22/2024Q4 23
Teleflex Incorporated stock logo
TFX
Teleflex
$3.26$3.38+$0.12$6.10$769.01 million$773.90 million      
2/20/2024Q4 2023
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.59$0.60+$0.01$1.09$608.21 million$616.53 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
NuVasive, Inc. stock logo
NUVA
NuVasive
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.360.65%N/A18.06%N/A

Latest GMED, IART, NUVA, and TFX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/22/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Quarterly$0.340.57%2/29/20243/1/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.10
4.88
2.72
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
0.94
3.45
2.18
NuVasive, Inc. stock logo
NUVA
NuVasive
0.50
1.25
0.65
Teleflex Incorporated stock logo
TFX
Teleflex
0.39
2.32
1.29

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
84.78%
NuVasive, Inc. stock logo
NUVA
NuVasive
N/A
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
24.30%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3.10%
NuVasive, Inc. stock logo
NUVA
NuVasive
0.53%
Teleflex Incorporated stock logo
TFX
Teleflex
1.43%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
5,000135.37 million102.48 millionOptionable
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3,94678.60 million76.17 millionOptionable
NuVasive, Inc. stock logo
NUVA
NuVasive
3,00052.45 million52.17 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
14,50047.10 million46.43 millionOptionable

GMED, IART, NUVA, and TFX Headlines

SourceHeadline
Raymond James Financial Services Advisors Inc. Trims Holdings in Teleflex Incorporated (NYSE:TFX)Raymond James Financial Services Advisors Inc. Trims Holdings in Teleflex Incorporated (NYSE:TFX)
marketbeat.com - April 15 at 4:27 AM
DekaBank Deutsche Girozentrale Has $1.74 Million Position in Teleflex Incorporated (NYSE:TFX)DekaBank Deutsche Girozentrale Has $1.74 Million Position in Teleflex Incorporated (NYSE:TFX)
marketbeat.com - April 14 at 5:19 AM
Guru Fundamental Report for TFX - Benjamin GrahamGuru Fundamental Report for TFX - Benjamin Graham
nasdaq.com - April 13 at 9:49 AM
Sequoia Financial Advisors LLC Makes New $1.72 Million Investment in Teleflex Incorporated (NYSE:TFX)Sequoia Financial Advisors LLC Makes New $1.72 Million Investment in Teleflex Incorporated (NYSE:TFX)
marketbeat.com - April 13 at 6:40 AM
Teleflex Incorporated (NYSE:TFX) Shares Sold by Lawson Kroeker Investment Management Inc. NETeleflex Incorporated (NYSE:TFX) Shares Sold by Lawson Kroeker Investment Management Inc. NE
marketbeat.com - April 11 at 3:56 PM
Villere ST Denis J & Co. LLC Reduces Stock Position in Teleflex Incorporated (NYSE:TFX)Villere ST Denis J & Co. LLC Reduces Stock Position in Teleflex Incorporated (NYSE:TFX)
marketbeat.com - April 8 at 12:23 PM
Teleflex (TFX) Debuts the New Unified UroLift 2 System With ATCTeleflex (TFX) Debuts the New Unified UroLift 2 System With ATC
zacks.com - April 8 at 9:21 AM
Teleflex Unveils Advanced Tissue Control for UroLift 2 System, Revolutionizing BPH TreatmentTeleflex Unveils Advanced Tissue Control for UroLift 2 System, Revolutionizing BPH Treatment
msn.com - April 5 at 10:39 AM
Boston Trust Walden Corp Has $56.82 Million Holdings in Teleflex Incorporated (NYSE:TFX)Boston Trust Walden Corp Has $56.82 Million Holdings in Teleflex Incorporated (NYSE:TFX)
marketbeat.com - April 4 at 11:30 PM
Teleflex catheterization kit recall linked to 10 injuries, 1 deathTeleflex catheterization kit recall linked to 10 injuries, 1 death
medtechdive.com - April 4 at 2:34 PM
Research Analysts Issue Forecasts for Teleflex Incorporateds FY2025 Earnings (NYSE:TFX)Research Analysts Issue Forecasts for Teleflex Incorporated's FY2025 Earnings (NYSE:TFX)
marketbeat.com - April 3 at 6:31 AM
Teleflex launches UroLift 2 with advanced tissue controlTeleflex launches UroLift 2 with advanced tissue control
massdevice.com - April 2 at 5:35 PM
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate TypesTeleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
finance.yahoo.com - April 2 at 8:41 AM
Teleflex Sets Ambitious Climate Targets, Validated by Science Based Targets InitiativeTeleflex Sets Ambitious Climate Targets, Validated by Science Based Targets Initiative
msn.com - April 1 at 12:54 AM
AMI Asset Management Corp Has $18.86 Million Stock Position in Teleflex Incorporated (NYSE:TFX)AMI Asset Management Corp Has $18.86 Million Stock Position in Teleflex Incorporated (NYSE:TFX)
marketbeat.com - March 30 at 11:21 PM
LGT Capital Partners LTD. Purchases 190,950 Shares of Teleflex Incorporated (NYSE:TFX)LGT Capital Partners LTD. Purchases 190,950 Shares of Teleflex Incorporated (NYSE:TFX)
marketbeat.com - March 29 at 9:43 AM
Teleflex Incorporated (NYSE:TFX) Short Interest Down 42.0% in MarchTeleflex Incorporated (NYSE:TFX) Short Interest Down 42.0% in March
marketbeat.com - March 28 at 10:30 AM
Teleflex’s Climate Targets Validated by the Science Based Targets InitiativeTeleflex’s Climate Targets Validated by the Science Based Targets Initiative
finance.yahoo.com - March 28 at 8:09 AM
Teleflexs Climate Targets Validated by the Science Based Targets InitiativeTeleflex's Climate Targets Validated by the Science Based Targets Initiative
globenewswire.com - March 28 at 6:30 AM
Teleflex Incorporateds (NYSE:TFX) Intrinsic Value Is Potentially 60% Above Its Share PriceTeleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 60% Above Its Share Price
finance.yahoo.com - March 24 at 5:05 PM
Teleflex Incorporated (NYSE:TFX) Shares Sold by Vanguard Group Inc.Teleflex Incorporated (NYSE:TFX) Shares Sold by Vanguard Group Inc.
marketbeat.com - March 20 at 4:56 AM
Teleflex Incorporated: Teleflex: Fair Value Estimate Revised Upward; Outlook Strong, but Acquisitions Warrant ScrutinyTeleflex Incorporated: Teleflex: Fair Value Estimate Revised Upward; Outlook Strong, but Acquisitions Warrant Scrutiny
finance.yahoo.com - March 19 at 12:15 AM
Deutsche Bank AG Increases Holdings in Teleflex Incorporated (NYSE:TFX)Deutsche Bank AG Increases Holdings in Teleflex Incorporated (NYSE:TFX)
marketbeat.com - March 18 at 4:44 AM
Guru Fundamental Report for TFXGuru Fundamental Report for TFX
nasdaq.com - March 16 at 1:30 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Globus Medical logo

Globus Medical

NYSE:GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Integra LifeSciences logo

Integra LifeSciences

NASDAQ:IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
NuVasive logo

NuVasive

NASDAQ:NUVA
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.
Teleflex logo

Teleflex

NYSE:TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.